We would like to celebrate the exceptional career and retirement of Dr. Norman Stockbridge, whose leadership and dedication to the Cardiology & Nephrology Division of the @FDA has fostered an incredibly successful team. Wishing you the best during your well-deserved retirement.

Incredible experience at INOVA with world-renowned cardiology experts! @vbluml @AnaBaracCardio @GarimaVSharmaMD Thank you AHA @American_Heart for the grant and Vanessa for making this happen! I'm grateful for your support @coconnormd @ShashankSinhaMD @JamieLWKennedy @mpsotka

HF drug development, work of @HFCollaboratory over the years outlined in #JACCHF Global collaboration, innovative trials and other measures to accelerate development of new therapies are discussed @vbluml @mfiuzat @JJheart_doc @mpsotka, @coconnormd https://t.co/wWvXuHt5VM

How can we streamline, automate, and improve, CV clinical trials with #AI? Our @hfcollaboratory review in @JACCJournals outlines opportunities in enrollment, adjudication, and dissemination, & role of the FDA. Let's move from potential to reality! @hmkyale @JJheart_doc

HAPPENING NOW! 📊Our Statistical Concepts Meeting is starting off strong with introductions to Data Trial Borrowing from experts Don’t forget to tune in to hear from our panelists and open discussion!

Whether you're a device guru or someone who can't seem to remember anything about HF devices, this new Scientific Statement from the @HFSA has something for you! Check it out @JCardFail! 🔗 https://t.co/7LOTqJ59WJ

Apply now to be the editor in chief of the new JCF Intersections! Huge opportunity to launch a premier HF journal focusing on intersections with HF and other disciplines Deadline is next Friday November 1 DM me with questions @dranulala @DrMarthaGulati @HFSA @DukeHFDoc

Want to see the late breaking results from #heartfailure trials STEP-HFpEF, FINEARTS-HF, HuMAIN-HFpEF, and others? Details and recordings for both Late Breaking Clinical Research sessions are available now: https://t.co/gOehLLPnLF

Congratulations @ShashankSinhaMD! @JCardFail is fortunate to have your expertise and guidance in this important role. @coconnormd

Congratulations to @ShashankSinhaMD on being named the new Deputy Editor of @JCardFail! Very well-deserved.

JCF is excited to welcome @ShashankSinhaMD as our new Deputy Editor! 🌟 Dr. Sinha, an expert in advanced HF, mechanical circulatory support & transplant cardiology, also leads critical care at Inova Fairfax. He's been with JCF since 2021 as an Associate Editor. Congratulations!

Did you miss @HFSA 2024 in ATL? Unfortunately we all did. Luckily @JCardFail has all the LBCT updates and meeting highlights: -STEP-HFpEF -FINEARTS-HF -HELIOS-B -EMBARK HFpEF -ARIES-HM3 -HuMAIN-HFpEF -PROACTIVE-HF -FUTURE-HF2 -CORTA-HF -CARE-HK And more… https://t.co/jIOq2wlOw3

We wanted to let you know that all registration fees for #HFSA2024 will be refunded in full, with the refunds processing over the coming weeks. See the full statement in the image and link below. https://t.co/f4n6Ork1Nh

Following HF🏥, higher loop diuretic independently associated with worse clinical ➕ patient-reported outcomes, regardless of loop diuretic used. https://t.co/lSIhStDs9D @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @robmentz @NinaNouhravesh

HAPPENING NOW! Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) Click the link below to watch the meeting with HFC members @JavedButler1 @coconnormd Jim Carr, and Janet Wittes https://t.co/GI57d55Qd1 @mfiuzat @mpsotka @dranulala @robmentz

Don’t forget to register for our Novel Statistical Concepts for HF Drug & Device Development Meeting📆 (Nov. 1) Topics will cover… ➖ Trial Data "Borrowing" ➖Interim Analysis ➖ Expanded Endpoints in HF https://t.co/mCfcrICH6t Fellows/trainees should contact us for discount!

Impact of diuretic dosing on clinical outcomes investigated by N Nouhravesh, @mpsotka et al through post hoc analysis of TRANSFORM-HF in @ESCHeartFailure @coconnormd https://t.co/b0HZEnWl2H

📌Diuretic dosing & outcomes w/ torsemide & furosemide following hospitalization for #HeartFailure: The #TRANSFORMHF trial #HF #CardioRenal

Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial higher loop diuretic dosing was independently associated with worse clinical and patient-reported outcomes https://t.co/gdYgZ0siVl

Thrilled to announce the growth of the JCF Family of Journals Launch of 💜JCF Intersections💜 Unmet need for a dedicated HF journal focusing on intersection of HF with other disciplines & a spotlight on multi-disciplinary teams! Apply now to be the new Editor in Chief!